Estrella Immunopharma, Inc. (ESLAW) community
ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.03 (-28.82%)
Close on Nov 17, 2026Market cap $16.53MP/E –Yield –
Community
Notes and questions about Estrella Immunopharma from other investors
No posts about ESLAW yet
Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.
See a number that looks wrong?